Table 1. Baseline characteristics of study population.
| Hypertensive event (N = 6243) |
No event (N = 256684) |
p | |
|---|---|---|---|
| Age | 57.0 (IQR, 47.0–69.0) | 41.0 (IQR, 30.0–52.0) | <0.001 |
| Sex | <0.001 | ||
| Male | 2964 (47.5%) | 128933 (50.2%) | |
| Female | 3279 (52.5%) | 127751 (49.8%) | |
| Household income level | <0.001 | ||
| High (8-10th decile) | 1580 (25.3%) | 59987 (23.4%) | <0.001 |
| Middle (4-7th decile) | 2110 (33.8%) | 101390 (39.5%) | <0.001 |
| Low (1-3th decile and medical assistance beneficiary) | 2553 (40.9%) | 95307 (37.1%) | <0.001 |
| Comorbidities | |||
| Hypertension | 3440 (55.1%) | 33513 (13.1%) | <0.001 |
| Diabetes mellitus | 957 (15.3%) | 12344 (4.8%) | <0.001 |
| Dyslipidemia | 1567 (25.1%) | 25256 (9.8%) | <0.001 |
| Atrial fibrillation/flutter | 82 (1.3%) | 762 (0.3%) | |
| Ischemic heart disease | 590 (9.5%) | 6001 (2.3%) | <0.001 |
| Peripheral arterial disease | 701 (11.2%) | 9157 (3.6%) | <0.001 |
| Chronic renal failure | 179 (2.9%) | 1071 (0.4%) | <0.001 |
| End-stage renal disease | 88 (1.4%) | 334 (0.1%) | <0.001 |
| Advanced liver disease | 162 (2.6%) | 1951 (0.8%) | <0.001 |
| Chronic obstructive pulmonary disease | 207 (3.3%) | 3146 (1.2%) | <0.001 |
| Malignancy | 318 (5.1%) | 7644 (3.0%) | <0.001 |
| Outpatient visit for hypertension within 3 months | 4186 (67.1%) | 35535 (13.8%) | <0.001 |
| Occurrence of outcome events | |||
| Major cardiovascular event | 643 (10.3%) | 6853 (2.7%) | <0.001 |
| Acute coronary syndrome | 129 (2.1%) | 1430 (0.6%) | <0.001 |
| Revascularization | 104 (1.7%) | 1177 (0.5%) | <0.001 |
| Stroke | 349 (5.6%) | 4125 (1.6%) | <0.001 |
| Admission for heart failure | 108 (1.7%) | 823 (0.3%) | <0.001 |
| Pacemaker application | 18 (0.3%) | 125 (0.0%) | <0.001 |
| Cardiovascular death | 118 (1.9%) | 1053 (0.4%) | <0.001 |
IQR, interquartile range